Mupirocin Infectopharm

Mupirocin, the active ingredient in Mupirocin Infectopharm, is an antibiotic presented as a topical preparation for skin application. It treats localized bacterial skin infections such as impetigo, folliculitis and secondary infections in patients of various ages.

GNH USA supplies Mupirocin Infectopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mupirocin is a topical antibiotic used to manage bacterial skin conditions. - Impetigo: eradicates Staphylococcus aureus and Streptococcus pyogenes causing crusted lesions. - Secondary bacterial skin infections: reduces bacterial load in wounds or dermatitis. - Folliculitis and furunculosis: clears infection of hair follicles and boils, promoting healing.

Mupirocin may cause local skin reactions and, rarely, systemic hypersensitivity.

Common Side Effects: - Burning or stinging at the application site. - Itching or mild irritation. - Redness or erythema. - Dryness or peeling of the skin. - Localized rash. - Mild swelling.

Serious or Rare Side Effects: - Allergic contact dermatitis. - Severe skin reactions such as Stevens‑Johnson syndrome. - Anaphylaxis. - Systemic infection due to bacterial resistance. - Significant swelling or blistering. - Persistent ulceration at the site of application.

Mupirocin should be used with attention to specific safety considerations. - Apply to affected area only: avoid eyes, mouth and large open wounds. - Do not use on extensive body surface area without medical supervision. - Avoid if known hypersensitivity to mupirocin or any component of the formulation. - Seek medical advice if infection worsens or does not improve within several days. - Discuss use during pregnancy or lactation with a healthcare professional. - Store at below 25°C: keep in the original container, protect from moisture and heat.

Mupirocin may interact with other agents applied to the skin.

Major Interactions (Avoid): - Concurrent use with other topical antibiotics may increase resistance risk. - Combination with systemic antibiotics sharing the same spectrum may reduce overall efficacy. - Use with immunosuppressive agents may heighten infection risk.

Moderate Interactions (Monitor Closely): - Co‑application with moisturizers may alter drug absorption. - Use with corticosteroid creams may modify local anti‑infective effect. - Application over dressings containing silver or iodine may affect activity. - Interaction with topical antiseptics may cause irritation. - Use with occlusive bandages may increase systemic absorption.